Nutex Health Soars 93.8% on Record Revenue

Nutex Health's stock price rose to $34.17 in pre-market trading on April 1, 2025, reflecting strong investor sentiment following the company's recent financial performance.

Nutex Health reported robust financial results for the fourth quarter and full year of 2024. The company's total revenue for the year reached $479.9 million, marking a significant increase of 93.8% compared to $247.6 million in 2023. This substantial growth in revenue was accompanied by a net income of $52.2 million, a stark contrast to the net loss of $45.8 million reported in 2023.

In the fourth quarter of 2024, Nutex Health's revenue was $81.30 million, slightly exceeding the expected revenue of $81.13 million. This positive performance indicates the company's ability to meet and surpass market expectations, contributing to the overall positive investor sentiment.